Sign in Get started

Infectious Diseases

Filters3 filters applied

Status

Corrected
No notice
From publisher notices and Retraction Watch. Not checked means nobody has looked yet.

Year

Readable here

Study type

Licence

CC BY

8 papers1 Corrected 6 with full text Questions on this topic

2 filters appliedStudy type: Randomised trial Year: 2020 and later Clear all

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients
Roman Reindl-Schwaighofer, Andreas Heinzel, Manuel Mayrdorfer et al. · JAMA Internal Medicine · 2022 · Randomised trial
Full textCC BY
Corrected
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin, Jeannie Callum, Erin Jamula et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
Angela Choi, Matthew Koch, Kai Wu et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Jean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier et al. · The Lancet Respiratory Medicine · 2021 · Randomised trial
Abstract only
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward, Philipe Gobeil, Annie Séguin et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Arvind Gharbharan, Carlijn C. E. Jordans, Corine GeurtsvanKessel et al. · Nature Communications · 2021 · Randomised trial
Full textCC BY
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Christopher C Butler, Jienchi Dorward, Ly-Mee Yu et al. · The Lancet · 2021 · Randomised trial
Abstract only
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Maryam Edalatifard, Maryam Akhtari, Mohammadreza Salehi et al. · European Respiratory Journal · 2020 · Randomised trial
Full textCC BY